Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eiger Biopharma (NQ: EIGR )

0.3584 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eiger Biopharma

< Previous 1 2 3 Next >
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. 
Via Benzinga
Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint
Via Benzinga
Eiger BioPharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment
Via Benzinga
Eiger BioPharmaceuticals' Debt Overview
Shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) decreased by 85.08% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to... 
Via Benzinga
Dow Rises 150 Points; US Jobless Claims Increase To 230,000
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million. 
Via Benzinga
Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in... 
Via Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
Via Benzinga
EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Nasdaq Drops 100 Points; DWAC Shares Plummet
U.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around... 
Via Benzinga
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
  
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... 
Via Benzinga
US Stocks Trade Lower; Dow Drops Over 100 points
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%,... 
Via Benzinga
Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
According to Benzinga Pro data, during Q2, Eiger BioPharmaceuticals (NASDAQ:EIGR) posted sales of $4.09 million. Earnings were up 3.35%, but Eiger BioPharmaceuticals still reported an overall loss of... 
Via Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
  
Via Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
Via Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan... 
Via Benzinga
Mid-Morning Market Update: Markets Edge higher; US Weekly Jobless Claims Drop To 214,000
U.S. stocks traded slightly higher this morning following the release of weekly jobless claims data on Thursday. Following the market opening Thursday, the Dow traded up 0.06% to... 
Via Benzinga
Why Eiger BioPharmaceuticals Stock Is Jumping Today
Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced data from the Phase 3 TOGETHER study evaluating Peginterferon Lambda in non-hospitalized COVID-19 adult patients at high risk of progressing to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million.... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.